Effect of Modeling Resin on Anterior Direct Composite Veneer

June 26, 2024 updated by: Sarah Azzazy ali, Cairo University

Clinical Performance of Direct NanoHybrid Resin Composite Veneer Restorations Applied With or Without Modeling Resin:a Randomized Controlled Trial

the study will be conducted to evaluate the clinical performance of direct Nanohybrid resin composite veneer restorations applied with or without modeling resin

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

ChatGPT This study aims to investigate the impact of modeling resin on the clinical performance of direct nanohybrid resin composite veneer restorations in anterior teeth. Resin composites are widely used in dental restorations due to their aesthetic qualities, but issues like discoloration and surface roughness can affect their longevity and patient satisfaction. Modeling resin, used to aid in composite placement and sculpting, has become common, but concerns exist regarding its effects on composite properties, particularly long-term color stability.

The research will employ a randomized controlled trial design with a two-arm parallel approach. Adult patients (18-45 years) with anterior tooth defects suitable for composite veneer restoration will be recruited. The intervention group will receive nanohybrid resin composite with modeling resin, while the comparator group will receive the composite without modeling resin. Outcomes will be assessed using modified USPHS criteria, including color stability, color match, anatomical form, marginal adaptation, marginal discoloration, retention rate, presence of secondary caries, and postoperative sensitivity, at baseline and at follow-up intervals of 1, 3, 6, and 12 months.

Statistical analysis will involve independent t-tests for intergroup comparisons and repeated measures ANOVA for intragroup comparisons, with a significance level set at 0.05. The study aims to determine if the use of modeling resin influences the clinical outcomes of resin composite veneer restorations. Ethics approval will be obtained, and confidentiality of participant data will be strictly maintained throughout the study period.

Overall, this research seeks to provide insights into optimizing the application of resin composites in dental practice to enhance patient outcomes and satisfaction

Study Type

Interventional

Enrollment (Estimated)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • • Adults (18-45Ys) with anterior tooth defects indicated for direct composite veneer restoration.

    • Males or females.
    • Community-dwelling
    • Have all his/her anterior teeth with sufficient enamel structure
    • With ≥ 1 anterior tooth defect
    • Have sufficient cognitive ability to understand consent procedures
    • Anterior tooth defect indicated for direct composite veneer
    • Vital upper or lower anterior teeth with no signs or symptoms of irreversible pulpitis.
    • Mobility grade: no clinical mobility
    • Plaque index ≤ 2

Exclusion Criteria:

  • Patients younger than 18 or older than 45 years old • Disabilities.
  • Systemic diseases or severe medically compromised.
  • Lack of compliance.
  • Evidence of severe bruxism, clenching or temporomandibular joint disorders.
  • Cognitive impairment

Periapical pathosis or signs of pulpal pathology.

  • Malocclusion
  • Possible prosthodontic restoration within 1 year.
  • Non-vital tooth.
  • Endodontically treated tooth.
  • Severe periodontal affection or tooth indicated for extraction.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intervention
the use of Modeling resin as the last layer applied to the NanoHybrid composite direct veneer
it is the application of Modeling liquid to make easier manipulation and sculpting the composite veneer and reflect on its physical properties and clinical performance
Active Comparator: comparator
the regular application of the NanoHybrid composite as a direct anterior veneer restoration
it is the application of Modeling liquid to make easier manipulation and sculpting the composite veneer and reflect on its physical properties and clinical performance

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
comparison of Color stability with and without the intervention
Time Frame: baseline and after one year
by using Spectrophotometer to measure the color considering the intervention
baseline and after one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
comparing the effect of the intervention on color match
Time Frame: baseline and after one year
using the modefied USPHS criteria
baseline and after one year
comparing the effect of the intervention on anatomical form
Time Frame: baseline and after one year
using the modefied USPHS criteria
baseline and after one year
comparing the effect of the intervention on surface texture
Time Frame: baseline and after one year
using the modefied USPHS criteria
baseline and after one year
comparing the effect of the intervention on marginal adaptation
Time Frame: baseline and after one year
using the modefied USPHS criteria
baseline and after one year
comparing the effect of the intervention on marginal discoloration
Time Frame: baseline and after one year
using the modefied USPHS criteria
baseline and after one year
comparing the effect of the intervention on retention rate
Time Frame: baseline and after one year
using the modefied USPHS criteria
baseline and after one year
comparing the effect of the intervention on postoperative sensitivity
Time Frame: baseline and after one year
using the modefied USPHS criteria
baseline and after one year
comparing the effect of the intervention on recurrent caries
Time Frame: baseline and after one year
using the modefied USPHS criteria
baseline and after one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2024

Primary Completion (Estimated)

July 1, 2025

Study Completion (Estimated)

August 1, 2025

Study Registration Dates

First Submitted

June 26, 2024

First Submitted That Met QC Criteria

June 26, 2024

First Posted (Actual)

July 3, 2024

Study Record Updates

Last Update Posted (Actual)

July 3, 2024

Last Update Submitted That Met QC Criteria

June 26, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • MR in anterior

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe